Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate added to phenobarbital for prolonged neonatal jaundice
IRCT20201118049433N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Aug 2020
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in neonatal hyperbilirubinemia comparing Phenobarbital control with Fenofibrate + phenobarbital (2 arms). Primary endpoint: Total bilirubin. Started Aug 2020; status: completed.
02
Drugs
fenofibratephenobarbital
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20201118049433N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201118049433N1.